Peter Logalbo
Allergy · West Nyack, NYNPI 1700825395
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,091 and has fallen 80.0% since, to $219 in 2025.
Across 180 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$748
- Regeneron Healthcare Solutions, Inc.$375
- GSK$355
- Kaleo, Inc.$308
- Optinose US, Inc.$279
- Sanofi$229
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,53997%
- Education$1053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $748 |
| Regeneron Healthcare Solutions, Inc. | 14 | $375 |
| GSK | 22 | $355 |
| Kaleo, Inc. | 17 | $308 |
| Optinose US, Inc. | 15 | $279 |
| Sanofi | 11 | $229 |
| Novartis | 12 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $155 |
| Grifols USA, LLC | 8 | $141 |
| Genentech USA, Inc. | 7 | $132 |
| Amgen | 7 | $105 |
| Pfizer | 7 | $97 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $86 |
| Inspire Medical Systems, Inc. | 4 | $72 |
| Stryker | 1 | $58 |
| Alk-abello, Inc | 3 | $55 |
| Aerin Medical Inc. | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| CSL Behring | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $20 |
| Acclarent, Inc | 1 | $19 |
| Pharming Healthcare, Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,644 in reported general payments places this provider in the 60th percentile of 92 allergy providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,005 |
| Ipratropium Bromide | 11 | $667 |
| Fluticasone Propionate | 38 | $508 |
| Montelukast Sodium | 36 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $355 | $7,00512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 92 allergy providers in New York.
Other allergy in West Nyack
- David ResnickWest Nyack$694
- Marc BraunsteinHewlett$884K
- Allison RamseyRochester$643K
- Christopher SmithHorseheads$622K
- Anne MaitlandTarrytown$292K
- Yudhistira PersaudBronx$127K
- Michael KatlanAlbany$91K
- Michel AklJamestown$90K
- Juan SotomayorNorth Syracuse$64K
- Alan KaufmanMount Vernon$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.